Home

Ang Lifesciences India Ltd PE Ratio

Image

ANG Lifesciences India Ltd

NSE: ANGLIFESCIENCES

PE

-

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of ANG Lifesciences India Ltd is 0 as of 15 Jan 15:30 PM .
  • The P/E Ratio of ANG Lifesciences India Ltd changed from 6 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of ANG Lifesciences India Ltd is ₹ 43.06 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of ANG Lifesciences India Ltd

No data available

Company Fundamentals for ANG Lifesciences India Ltd

Image

ANG Lifesciences India Ltd

NSE: ANGLIFESCIENCES

Share Price

₹ 43.06

-0.19 (-0.44%)

stock direction

Last updated on: Jan 15, 2025

Market Price of ANG Lifesciences India Ltd

1M

1Y

3Y

5Y

Monitoring ANG Lifesciences India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202543.25
13 Jan 202541.69
10 Jan 202541.63
09 Jan 202543.67
08 Jan 202543.77
07 Jan 202543.17
06 Jan 202543.36
03 Jan 202544.28
02 Jan 202544.75
01 Jan 202545.49

SWOT Analysis Of ANG Lifesciences India Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for ANG Lifesciences India Ltd

Asset Value vs Market Value of ANG Lifesciences India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
ANG Lifesciences India Ltd56.48
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of ANG Lifesciences India Ltd Explained

``

56.48

Market cap

-14

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of ANG Lifesciences India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of ANG Lifesciences India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of ANG Lifesciences India Ltd

No data available

* All values are in %

About ANG Lifesciences India Ltd

  • ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006.
  • On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010.
  • The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010.
  • Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials.
  • In 2008-09, the Company started its commercial production.

ANG Lifesciences India Ltd News Hub

ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter

Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as again

Read more

2024-08-16 00:00:00

ANG Lifesciences India to discuss results

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 August 202

Read more

2024-08-12 00:00:00

ANG Lifesciences India to convene AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held o

Read more

2024-09-19 00:00:00

ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held o

Read more

2024-09-19 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of ANG Lifesciences India Ltd

What is the current PE Ratio of ANG Lifesciences India Ltd?

The Current PE Ratio of ANG Lifesciences India Ltd is 0.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of ANG Lifesciences India Ltd last year?

The PE Ratio of ANG Lifesciences India Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of ANG Lifesciences India Ltd indicate about its stock?

The PE Ratio of ANG Lifesciences India Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of ANG Lifesciences India Ltd.

What is the PE Ratio Growth of ANG Lifesciences India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of ANG Lifesciences India Ltd grew by -% whereas, the EPS ratio grew by -34.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions